Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Novo Nordisk A/S Health & Science Health care industry
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags Health & Science Health care industry Eli Lilly and Co
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Companies Health & Science Health care industry
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Biotech and Pharmaceuticals Social issues Healthy Returns
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Health & Science Health care industry Berkshire Hathaway Inc
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Europe Markets Eli Lilly and Co Markets
From CNBC.com News
CNBC Daily Open: Everyone's waiting for Nvidia
Tags Broadcom Inc Nordstrom Inc NVIDIA Corp
From CNBC.com News
CNBC Daily Open: Stocks up ahead of Nvidia earnings
Tags World Markets Advanced Micro Devices Inc Salesforce Inc
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Entertainment Technology Business
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Novo Nordisk A/S Biotechnology Business
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Meta Platforms Inc Stock markets Universal Health Services Inc
From CNBC.com News
CNBC Daily Open: A 'crazy' summer
Tags JD/Com Inc Market Outlook Economic events
From CNBC.com News
CNBC Daily Open: 'Crazy' summer
Tags Retail sales Hedge Funds Investment banking and brokerage
From CNBC.com News
Wednesday's big stock stories: What's likely to move the market in the next trading session
Tags Netflix Inc Starbucks Corp Macy's Inc
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Biotech and Pharmaceuticals Breaking news Biotechnology
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Companies Health care industry US: News
From CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
Tags KOHLS CORP DRN Nuscale Power Corp Investing
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Health & Science Health care industry Eli Lilly and Co
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
Tags Business Business News Investing
From CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
Tags Business News Business Biotechnology
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Under Armour Inc Ulta Beauty Inc ETSY Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy Uber Technologies Inc Apple Inc
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Novo Nordisk A/S Breaking News: Business Business
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Business News Biotechnology Business
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Viking Therapeutics Inc Altimmune Inc Biotech and Pharmaceuticals
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Science Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business Biotechnology Novo Nordisk A/S
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Biotech and Pharmaceuticals Business Biotechnology
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Breaking news Biotech and Pharmaceuticals Viking Therapeutics Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.